Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
maestro1
Posted in: GDR
Posts: 10,683
The wording of rns suggest the eua is not imminent..This is concerning..
BBenchWhen ceo states they have daily contact with fda and dont know when they expect it, why are you so confident..
JimihendrixRead rns without eua they struggling to get sales in usa.They have CE mark in europe but no one wants to touch them.Come on be honest..
Are you misleading, those are the the ones they bought to set up for sales tp show clients.How many tests are worth 400k?
Its telling the way placing was done last year, 160p sp but done at 80p.Very dissapointed with Budd should resign.
Selling in germany, dont sysmex also distribute in germany for gdr, they have had no luck also.The mkt share has been taken, gdr are late to party.
SolstaceI have you to thank. I would have been significantly in red. 80% of my portfolio at the time..
"Fool me once, shame on you. Fool me twice, shame on me.”
BigbenchTrying to save job
Claiming to be longtermers lol
I thought beckman said tests are selling?
BigbenchNo price sensitive info will be issued 2morrow
How many shares u hold now?
They have been processing it for months, middle of pandemic we r.
High risk now for certain.
Budd says he doesnt know when they will get eua.This is concerning after 1 year...
John henryPcr will be useless in 6 months.
By the time eua granted new technology will be out and pcr test will be too expensive and not needed.Budd cant sell in middle of pandemic in europe.
Why are they not buying then?I pointed out yesterday, last result blamed regulatory clearances, this year still waiting. This was inevitable...
PhilStop clutching at straws, its been over 4 months he said that.
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE